Updated on 25 October 2026
SMEs seeking a Horizon Europe Health 2027 consortium: joint entry with an exploitation partner
Founder & Commercial Director at AxioTechBio
Paris, France
About
Many SMEs with strong technologies in diagnostics, omics, bioinformatics or medtech are looking for a coordinator for the Horizon Europe Cluster 1 Health 2027 calls (first deadline 17 February 2027).
AxioTechBio is an exploitation and go-to-market partner for Health 2027 consortia. We work with SMEs from across Europe to:
– Identify coordinators and consortia where their technology fits the topic (e.g. IND-02, TOOL-01, CARE-02, DISEASE-01)
– Approach coordinators jointly, as an SME + exploitation package that strengthens the Impact section of the proposal
– Define the exploitation route of the SME's results within the project
– Plan market uptake of project results in France and Spain (hospital laboratories, research centres, public procurement), with monitoring of the Nordic markets
Looking for:
– SMEs and start-ups in diagnostics, molecular biomarkers, omics, bioinformatics, medtech or digital health seeking a Health 2027 consortium
– SMEs that want to strengthen the exploitation and market uptake part of their participation
After the project, AxioTechBio can also support the SME's commercial launch in France and Spain.
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Type
- Consortium/Coordinator seeks Partners
Attached files
Organisation
Similar opportunities
Project cooperation
Exploitation, go-to-market & industry partner for Cluster 1 Health 2027 consortia
- Partner seeks Consortium/Coordinator
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Eduard Garcia
Founder & Commercial Director at AxioTechBio
Paris, France
Project cooperation
Seeking regulatory (IVDR/MDR) & HTA partners to build complementary exploitation teams
- Consortium/Coordinator seeks Partners
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Eduard Garcia
Founder & Commercial Director at AxioTechBio
Paris, France
Project cooperation
Exploitation & go-to-market partner for Point-of-Care diagnostics (HLTH-2027-02-IND-02)
- Partner seeks Consortium/Coordinator
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Eduard Garcia
Founder & Commercial Director at AxioTechBio
Paris, France